Literature DB >> 14720619

Emergency contraception: prescribing practices of general internists compared with other primary care physicians.

C H Chuang1, L J Waldman, K M Freund, A S Ash.   

Abstract

Primary care physicians of all specialties should be familiar with prescribing emergency contraception (EC). We conducted a mail survey of 282 randomly sampled physicians in general internal medicine (31%), family medicine (34%) and obstetrics-gynecology (35%). Experience with prescribing EC significantly differed by specialty (63% of general internists, 76% of family physicians, and 94% of obstetrician-gynecologists, p < 0.0001). Controlling for year of graduation, gender, religion and practice location, family physicians [adjusted odds ratio (OR): 2.5, 95% confidence interval (CI): 1.2-5.2] and obstetrician-gynecologists (adjusted OR: 11.2, 95% CI: 4.0-31.3) were still significantly more likely to have ever prescribed EC than general internists. Efforts to increase awareness and knowledge of EC should be aimed at general internists since they provide primary care for many reproductive age women.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14720619     DOI: 10.1016/j.contraception.2003.09.003

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  3 in total

1.  Religious hospitals and primary care physicians: conflicts over policies for patient care.

Authors:  Debra B Stulberg; Ryan E Lawrence; Jason Shattuck; Farr A Curlin
Journal:  J Gen Intern Med       Date:  2010-04-06       Impact factor: 5.128

2.  Emergency contraception: knowledge and attitudes of Nova Scotian family physicians.

Authors:  Donald B Langille; Michael Allen; Anne Marie Whelan
Journal:  Can Fam Physician       Date:  2012-05       Impact factor: 3.275

3.  Do Indonesian medical practitioners approve the availability of emergency contraception over-the-counter? A survey of general practitioners and obstetricians in Jakarta.

Authors:  Dyna E Syahlul; Lisa H Amir
Journal:  BMC Womens Health       Date:  2005-03-22       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.